Bioresorbable Scaffolds Market Size, Share, and Growth Analysis, By Material Type (Polymer-based Scaffolds, Metallic Scaffolds), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-user, By Region - Industry Forecast 2025-2032
Bioresorbable Scaffolds Market size was valued at USD 1.71 billion in 2023 and is poised to grow from USD 2.04 billion in 2024 to USD 8.5 billion by 2032, growing at a CAGR of 19.5% during the forecast period (2025-2032).
The bioresorbable scaffolds market is experiencing robust growth propelled by technological advancements and a rising prevalence of cardiovascular diseases. These temporary implants, designed to treat coronary artery disease by gradually dissolving, allow for natural vessel healing. Dominated by polymer-based materials due to their biocompatibility, the market also addresses diverse applications, predominantly in cardiovascular treatment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, driven by increased cardiac intervention admissions. Geographically, North America leads in market share, supported by advanced healthcare systems, followed by Europe with its research focus, and a growing Asia-Pacific region due to healthcare investments and an aging demographic. Despite challenges like costs and the need for skilled professionals, ongoing research suggests promising market expansion ahead.
Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Bioresorbable Scaffolds Market Segments Analysis
Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Bioresorbable Scaffolds Market
The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, significantly propels the growth of the bioresorbable scaffolds market. As these health issues become more prevalent, there is an increasing need for advanced therapeutic options that can effectively restore blood flow. This situation fosters a strong demand for innovative medical solutions, such as bioresorbable scaffolds, which offer unique advantages in the treatment of vascular conditions. The ability of these scaffolds to provide temporary support to blood vessels while gradually dissolving is particularly appealing to healthcare providers looking to improve patient outcomes, further driving market expansion.
Restraints in the Bioresorbable Scaffolds Market
The bioresorbable scaffolds market is confronted with a significant obstacle due to the shortage of long-term clinical evidence. There remains a pressing need for comprehensive evaluations of the performance of bioresorbable scaffold implants in comparison to conventional stents. This lack of conclusive data on their efficacy and safety could hinder healthcare professionals from fully embracing these innovative solutions, potentially affecting adoption rates. As a result, the industry must prioritize the generation of robust clinical studies to substantiate the long-term benefits and reliability of bioresorbable scaffolds, ensuring that they can be confidently integrated into patient care practices.
Market Trends of the Bioresorbable Scaffolds Market
The bioresorbable scaffolds market is experiencing a notable surge, primarily driven by the rising geriatric population, which necessitates enhanced healthcare solutions. As the elderly demographic becomes more predominant, their susceptibility to cardiovascular diseases escalates, creating a substantial demand for innovative treatment options. Bioresorbable scaffolds offer a compelling alternative due to their ability to support vascular structures temporarily and then dissolve, eliminating the need for additional surgical interventions. This trend indicates a shift towards patient-centric approaches in cardiology, with healthcare providers increasingly adopting biocompatible materials to improve patient outcomes and overall quality of life in an aging society.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Patent Analysis
Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2025-2032)
Market Overview
Polymer-based Scaffolds
Metallic Scaffolds
Global Bioresorbable Scaffolds Market Size by Application & CAGR (2025-2032)
Market Overview
Coronary Artery Disease
Peripheral Artery Disease
Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2025-2032)
Market Overview
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories
Global Bioresorbable Scaffolds Market Size & CAGR (2025-2032)
North America (Material Type, Application, End-user)
US
Canada
Europe (Material Type, Application, End-user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Material Type, Application, End-user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Material Type, Application, End-user)
Brazil
Rest of Latin America
Middle East & Africa (Material Type, Application, End-user)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Abbott Laboratories (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Boston Scientific Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Terumo Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Biotronik SE & Co. KG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
REVA Medical, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Elixir Medical Corporation (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Amaranth Medical, Inc. (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Arterial Remodeling Technologies (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Meril Life Sciences Pvt. Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Kyoto Medical Planning Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Lepu Medical Technology (Beijing) Co., Ltd. (China)